Velico Medical Announces A Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma

    Velico Medical Announces a Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma.   BARDA has extended its Spray Dried Plasma development contract with Velico Medical through November 2019 providing for an additional $18.9 million. This non-dilutive funding is expected to support the company’s development program through FDA approval to commence Phase I clinical trials.  Spray dried plasma is being developed as an alternative to frozen plasma and is expected to play a life-saving role wherever time to plasma transfusion is Continue reading →

Velico Medical Announces BARDA Exercise of $15.5 Million Contract Option

BEVERLY, MASSACHUSETTS (PRWEB) SEPTEMBER 09, 2015 Velico Medical today announced that the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA), has exercised its first option under its contract with Velico to further develop Velico’s Spray Dried Plasma technology (SpDP™). BARDA’s exercise of this option extends the contract through March 2017 and provides for up to approximately $15.5 million of additional funding to support the development of a system for spray drying plasma for transfusion. Spray dried plasma is being developed Continue reading →

Biomedical Advanced Research and Development Authority (BARDA)

Dried Plasma Device for CBRNE Mass Casualty Scenario OCTOBER 12, 2012 The Biomedical Advanced Research and Development Authority (BARDA) has awarded Velico Medical, Inc., a development contract worth up to $38.6 million for a device that could revolutionize emergency blood storage and shipment for use in chemical, biological, radiological, nuclear or high-yield explosive (CBRNE) or natural disaster emergencies. The spray-dry device would convert fresh liquid blood plasma into a sterile powder for more effective shipment and storage.  Current practices of utilizing frozen plasma pose logistical Continue reading →